A multicenter, randomized, double-blind, palcebo-controlled, parallel-group study of efficacy and safety of topiramate in weight loss maintenance in obese patients following participation in an intensive, non-pharmacologic weight loss program.
Phase of Trial: Phase III
Latest Information Update: 23 Jun 2009
At a glance
- Drugs Topiramate (Primary)
- Indications Obesity
- Focus Therapeutic Use
- Sponsors Janssen Research & Development
- 31 Aug 2018 Biomarkers information updated
- 23 Jun 2009 Actual patient number (561) added as reported by ClinicalTrials.gov.
- 14 May 2007 Status changed from in progress to completed.